← Eichor
Study identifier: NCT07233148 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Healing ALS Registry Observational Study (HAROS)

Condition: Amyotrophic Lateral Sclerosis (ALS) · Motor Neuron Disease (MND) · Primary Lateral Sclerosis (PLS)  ·  Sponsor: Healing Advocates Registry and Ministry

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to 110 Years
Healthy volunteersNo

About this study

This is a prospective, observational, online study of people diagnosed with ALS, MND or PLS referred to as HAROS (Healing ALS Registry Observational Study). Participants will enter information into an online ALS registry once per month, including their ALSFRS-R data, certain other symptoms, dietary intake, supplements, medications and other therapies, both conventional and integrative. Participants will also enter the hours spent on optional self-study and free online education. The investigators will assess the effectiveness of various therapies and education by measuring physical outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Healing ALS Study Administrator  ·  1-973-714-4621  ·  Study@HealingALS.org

Always discuss trial participation with your own doctor first.

Locations (1)

VirtualPark City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07233148